Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

NCT00361283 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT00361283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00361283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
January 31, 2009
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation